Terumo Corporation (TRUMY) EPS Estimated At $0.31

December 20, 2017 - By Richard Conner

 Terumo Corporation (TRUMY) EPS Estimated At $0.31

Analysts expect Terumo Corporation (OTCMKTS:TRUMY) to report $0.31 EPS on December, 21.TRUMY’s profit would be $110.11 million giving it 37.70 P/E if the $0.31 EPS is correct. It closed at $46.75 lastly. It is down 0.00% since December 20, 2016 and is . It has underperformed by 16.70% the S&P500.

Terumo Corporation manufactures and sells medical devices and services worldwide. The company has market cap of $16.61 billion. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion. It has a 30.1 P/E ratio. The firm offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems.

Another recent and important Terumo Corporation (OTCMKTS:TRUMY) news was published by Businesswire.com which published an article titled: “Top Insights on the Global Intravenous Access Devices Market| Technavio” on December 19, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.